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Abstract 
We developed two Ugi-type three-component reactions of spirooxindole-fused 3-thiazolines, isocyanides 
and either carboxylic acids or trimethylsilylazide, to give highly functionalized spirooxindole-fused 
thiazolidines. Two diverse libraries were generated using practical and robust procedures affording the 
products in typically good yields. The obtained thiazolidines proved to be suitable substrates for further 
transformations. Notably, both the Ugi-Joullié and the azido-Ugi reactions resulted highly diastereoselective, 
affording predominantly the trans-configured products, as confirmed by X-ray crystallographic analysis. 
Keywords: 
Thiazolidine, spirooxindole, multicomponent reactions, Asinger reaction, Ugi-Joullié reaction, azido-Ugi 
reaction. 
Introduction 
The field of diversity-oriented synthesis (DOS)1 has matured considerably since its introduction in the early 
2000s, providing numerous approaches for the generation of molecular diversity. The main challenge for DOS 
is the proper combination of a central scaffold diversity with a high degree of peripheral structural variability, 
considering scaffold diversity the most important feature for the specific interaction with the biological 
environment. In this regard, spirocycles have become attractive synthetic targets in drug discovery projects, 
for their inherent three-dimensional nature and concomitant ability to project functionalities in all three 
dimensions. Variation brought by appendage diversity, usually resulting in the variation of R-groups around 
a single scaffold, is less challenging but equally significant, taking into account that wider is the degree of 
structural variation among compounds within a library, the higher is the chance of achieving broad or distinct 
biological activity across that library.  
The goal of molecular diversity requires the application of efficient synthetic strategies, possibly involving a 
divergent approach, which allows the transformation of a small number of starting materials into many 
distinct structures. Owing to their ability to rapidly construct highly functionalized molecular scaffolds from 
simple precursors, multicomponent reactions (MCRs) can be considered excellent tools for DOS applications.2 
As part of our ongoing interest in 3,3-disubstituted oxindoles and spiro-fused analogues,3 we have recently 
reported the synthesis of spirooxindole-fused 3-thiazolines by means of an Asinger-type three-component 
reaction (structure 1, Scheme 1).4 
 Scheme 1. The two sequential multicomponent strategies described in this work. 
 
Spirooxindole-fused 3-thiazolines 1 represent an underexploited scaffold in the context of sulfur-containing 
spirooxindoles. They are in themselves endowed with R, R1 and R2 diversity, but can be also regarded as 
versatile intermediates towards peripheral diversity, because of the presence of the reactive C=N double 
bond.  
We demonstrate here the suitability of such spiro compounds as useful substrates for two highly 
diastereoselective, multicomponent transformations, namely the Ugi–Joullié and the azido-Ugi reaction, to 
give libraries of compounds 4 and 5, respectively. Although the strategy of sequential Asinger and Ugi 
reactions is already reported, mainly by Martens and coworkers,5 its extensive application to spirocyclic 
imines is quite unprecedented, as well as the  issue of diastereoselectivity has never been addressed so far. 
The unique application of the Asinger 4-CR/azido-Ugi 3-CR combination was reported by Dömling and 
coworkers,6 while, quite recently, the first example of diastereoselective azido-Ugi reaction was reported by 
Nenajdenko and coworkers,7 employing secondary amines. Summing, at the best of our knowledge, no 
examples of diastereoselective multicomponent transformations have been reported until now on thiazoline 
substrates.  
Being aware of the potential biological implication of this work and considering typical substituent patterns 
of bioactive related compounds (Figure 1),8 we provided to decorate the central spiro scaffold with a variety 
of lipophilic and polar functional groups, as well as with the pharmacological relevant tetrazole ring.  
 
Figure 1. Examples of biologically relevant compounds containing spirooxindoles, 
thiazolidine and tetrazole moieties.8 
 
By means of simple and rapid protocols, thirty-six compounds have been overall prepared, showing a wide 
degree of appendage diversity and a high diastereoisomeric ratio in most cases (dr up to 99:1 for the Ugi-
Joullié and 98:2 for the azido-Ugi).  
 
Results and Discussion 
Initially, racemic isatin-derived thiazoline 1{1}, tert-butyl isocyanide 2{1} and cyclohexyl carboxylic acid 3{1} 
were selected to optimize the conditions for the Ugi-Joullié reaction (Table 1). 
Relying on reaction conditions already reported for cyclic imines,9 we started considering aprotic solvents 
such as dichloromethane and toluene (entries 1-2), but the reaction was found to be sluggish. Working in 
more usual solvents for Ugi-type processes10 (MeOH, entry 3), the same reaction afforded the desired 
thiazolidine product in 55% yield as a readily separable 1:1 mixture of trans and cis diastereoisomers. 
Switching to more acidic trifluoroethanol (TFE) increased the reaction rate and yield (entry 4). It also favored 
a more diastereoselective process,11 leading to trans-isomer 4{1,1,1} as the major product (dr 75:25). The dr 
was further improved by increasing the concentration (0.5 M, entry 5), while either lowering the 
concentration (entry 6) or running the reaction at 0 oC (entry 7) reduced the conversion without improving 
the dr. 
 
Table 1. Optimization of the Ugi-Joullié 3-CR.a 
 
Entry Solvent Conc. [M] Time [h] Conversion (%)b dr [trans:cis]c 
1 CH2Cl2 0.25 24 trace nd 
2 Toluene 0.25 24 trace nd 
3 MeOH 0.25 24 55 50:50 
4 TFE 0.25 6 95 75:25 
5 TFE 0.5 4 95 (83)d 87:13 
6 TFE 0.125 6 85 76:24 
7e TFE 0.25 6 85 74:26 
 
a Reactions were performed on a 0.3 mmol scale, with 1{1}:2{1}:3{1} in a 1:1:1 ratio, at room temperature, unless otherwise 
indicated. b Evaluated by 1H NMR analysis of the crude mixture considering both diasteroisomers. c Determined by 1H NMR analysis 
of the crude mixture. d Isolated yield for the trans diasteroisomer. e Reaction performed at 0 °C. TFE = 2,2,2-trifluoroethanol. nd = 
not determined. 
 
 
 
 
 
 
Figure 2. Chemsets: thiazolines Chemset 1, isocyanides Chemset 2 and carboxylic acids Chemset 3. 
 
 
With the optimal conditions in hand, we investigated the scope and limitations of the protocol, varying the 
three components one at a time (Scheme 2, for reagents input see Figure 2). Reaction of oxindole-based 
thiazolines 1{1-8} with tert-butyl isocyanide 2{1} and cyclohexanecarboxylic acid 3{1} afforded the expected 
products 4{1-8,1,1} with good dr (up to 93:7 for compound 4{5,1,1}) and in generally reasonable to good 
yield, although moderate yields were observed for 4{2,1,1} and 4{7,1,1}. Next, different isocyanides 2{1-8} 
were combined with thiazoline 1{1} and carboxylic acid 3{1}. Compounds 4{1,1-8,1} were obtained in 
acceptable yields, with aliphatic isocyanides affording the best results (69% and 82% yield for compounds 
4{1,2,1} and 4{1,3,1}, respectively). Due to their lower stability in acidic media, isocyanoacetates 2{4,5} gave 
products 4{1,4,1} and 4{1,5,1} in lower yields. 
Scheme 2. Scope of the Ugi-Joullié 3-CR.a 
 
a Reactions were performed on a 0.3 mmol scale with 1:2:3 in a 1:1:1 ratio. Yields refer to isolated yield of the trans diasteroisomer. 
The dr’s were determined by 1H NMR analysis of the crude product (see the Supporting Information (SI) file, where such analysis is 
reported for compound 4{1,6,1}, as an example). nd = not determined. 
 
However, the highest dr was achieved in the reaction with tert-butyl isocyanoacetate (4{1,5,1}, dr 99:1). 
Good results were obtained with both phenyl and benzyl isocyanide (4{1,6,1} and 4{1,7,1}), whereas no 
product 4{1,8,1} was observed in the reaction with 2-morpholinoethyl isocyanide 2{8}.12 Finally, twelve 
different carboxylic acids were tested in the reaction with thiazoline 1{1} and tert-butyl isocyanide 2{1}. The 
resulting products 4{1,1,1-12} were obtained in generally high yields (up to 80%) and with satisfactory dr (up 
to 86:14), except compound 4{1,1,5} that was detected only in trace amounts. In this case, most likely the 
employed carboxylic acid [N-methylpiperidine-4-carboxylic acid] 3{5} was present in its zwitterionic form and 
therefore not reactive. In support of this hypothesis, the reaction with the 1-(tert-butoxycarbonyl)-
piperidine-4-carboxylic acid 3{6}, structurally similar but lacking basicity, furnished the expected UJ-3CR 
product 4{1,1,6} in good yield and dr. The wide variety of successfully tested carboxylic acids is noteworthy, 
ranging from phenylacetic acid to carboxylic acids containing both electron-rich and electron-deficient 
heterocycles (3{7-12}). 
We then moved on to the azido-Ugi process, optimizing the reaction conditions using racemic thiazoline 1{1}, 
tert-butyl isocyanide 2{1} and trimethylsilyl azide as the inputs (Table 2). Also in this case, the reaction was 
found to be sluggish in dichloromethane and toluene (entries 1-2), whereas excellent conversions to the 
target tetrazole derivative 5{1,1} were observed in polar protic solvents (entries 3-5). As for the above UJ-
3CR, fluorinated solvents (TFE and 1,1,1,3,3,3-hexafluoro-2-propanol, HFIP) led to a more a 
diastereoselective transformation, affording the trans diastereoisomer 5{1,1} as the major compound. 
Aiming to further improve the dr, different concentrations and temperatures were screened. We found that 
increasing the concentration in TFE led to a slight decrease in dr (entry 6), whereas lowering the temperature 
only gave a small improvement in dr (entry 7). Similarly, varying the concentration in HFIP did not lead to an 
appreciable improvement (entries 9,10), while in this case excellent diastereoselectivity was achieved at 0 °C 
(entry 11). 
 
 
 
 
  
Table 2. Optimization of the azido-Ugi 3-CR.a 
 
Entry Solvent Conc. [M] Time [h] Conversion (%)b dr [trans:cis]c 
1 CH2Cl2 0.5 24 <5 nd 
2 Toluene 0.5 24 <5 nd 
3 MeOH 0.5 2 95 56:44 
4 TFE 0.5 1 99 81:19 
5 HFIP 0.5 1 99 85:15 
6 TFE 1.0 1 99 78:22 
7 TFEd 0.5 1 99 83:17 
8 TFEe 0.5 1 99 83:17 
9 HFIP 1.0 1 99 84:16 
10 HFIP 0.05 1 99 82:18 
11 HFIPd 0.5 1 99 (87)f 92:8 
 
a The reactions were performed on a 0.15 scale with 1{1}:2{1}:TMS-N3 in a 1:1:1 ratio, at room temperature unless otherwise 
noted. 
b Evaluated on the crude mixture considering both diasteroisomers. 
c Determined by 1H NMR on the crude mixture. 
d 
Reaction performed at 0 °C. e Reaction performed at -18 °C. f Isolated yield for the trans diasteroisomer. TFE = 2,2,2-
trifluoroethanol. HFIP = 1,1,1,3,3,3-hexafluoro-2-propanol. nd = not determined. 
 
Next, we investigated the reaction scope, combining thiazolines 1{1-4} and 1{6} and isocyanides 2{1-3}, 2{5}, 
2{7}, 2{9-11} with trimethylsilyl azide, leading to good results in nearly all cases (Scheme 3). When aliphatic 
isocyanides were used, the corresponding products (5{1-4,1} and 5{6,1}, 5{1,2}, 5{1,9}, 5{1,3}, 5{1,10}, 
5{1,5}) were obtained in satisfactory yield and dr, with the exception of 5{1,9} (67:33 dr). Unlike the case of 
the UJ-3CR, tert-butyl isocyanoacetate 2{5} also worked well in the azido-Ugi reaction, affording the desired 
product 5{1,5} in 72% yield and with 84:16 dr. Finally, phenyl isocyanide 2{11} behaved similarly as in the UJ-
3CR, giving the corresponding product 5{1,11} in moderate yield and dr.  
 
Scheme 3. Scope of components in the azido-Ugi 3-CR.a 
 
a Reactions were performed on a 0.3 mmol scale, with 1{1}:2{1}:TMS-N3 in 1:1:1 ratio. For each product, the isolated yield for the 
trans diasteroisomer is reported. The indicated dr was determined by 1H NMR on the crude mixture. Compound 5{1,10} was 
obtained as a mixture of inseparable diastereoisomers. 
 
To determine the relative configuration for the two product types (4 and 5), single crystals of 4{1,1,1} and 
5{1,1} were subjected to X-ray crystallographic analysis, leading to the unambiguous assignment of the trans 
stereochemistry for both compounds (Figure 3). 
 
 
 
 
 
 
a) 
 
 
b) 
 
Figure 3. a) ORTEP view of compound 4{1,1,1} at room temperature. The methyl group on the left is rotationally disordered (see 
SI). Thermal ellipsoids of non-H atoms were drawn at the 50% probability level. b) ORTEP view of compound 5{1,1} at T = 105 K. 
Thermal ellipsoids of non-H atoms were drawn at the 50% probability level. 
 
Since all products 4 and 5 were obtained under the same conditions employed for compounds 4{1,1,1} and 
5{1,1}, respectively, and given common trends in 1H NMR chemical shifts as well as similarities in TLC 
retention factors (the trans-diastereoisomer always shows major Rf with respect to the cis- one), the same 
relative trans-stereochemistry was assigned to all products 4 and 5. 
To provide a plausible explanation for the highly diastereoselective outcome of both reactions, we consider 
the mechanism proposed in Figure 4 for the UJ-3CR. We presume that the preferred conformation of imine 
1{1} in solution is mainly determined by the spiro junction between the oxindole and the thiazoline ring 
system, with the latter adopting an envelope-like conformation oriented nearly perpendicularly with respect 
to the oxindole. This spatial arrangement highlights the substantial shielding of the Si-face of the imine for 
both steric and electronic reasons, mainly due to the proximity of the oxindole carbonyl. As a consequence, 
in strongly hydrogen-bonding solvents such as TFE and HFIP, the protonated imine exposes the convex Re-
face to the incoming isocyanide, affording predominantly the trans isomer (Figure 4, I). Taking into account 
the eﬀect of the solvent on the diastereoselectivity of the UJ-3CR involving a ﬁve-membered cyclic imine, as 
reported by Katsuyama et al.,11a we can also rationalize the poor reactivity observed in toluene. Indeed, in 
such nonpolar solvents, the protonation of the imine by the carboxylic acid likely results in the formation of 
a contact ion pair. This close interaction lowers the overall electrophilic reactivity of the imine and, more 
decisively, hinders the approach of isocyanide, shielding the sterically more available Re-face (Figure 4, II).  
 
Figure 4. Plausible explanation of the stereochemical outcome for the UJ-3CR. 
  
The use of MeOH as the solvent represents an intermediate scenario, providing sufficient activation for the 
reaction to occur, but very limited discrimination between the diastereotopic faces. Similar considerations 
on the molecular conformation of the imine component can be made to rationalize the high dr observed in 
the azido-Ugi 3-CR, that represented the first highly diasteroselective example on thiazoline-based 
compounds. 
Having established the reaction scope, further transformations were examined to extend the library of 
potentially useful compounds. Selected post-transformations of Ugi-Joullié products 4 are depicted in 
Scheme 4. Primary amide 6 is readily obtained by treatment of compound 4{1,2,1} with trifluoroacetic acid. 
Starting from compound 4{1,5,1}, cleavage of the tert-butyl ester afforded the free acid 7 in quantitative 
yield. Finally, the piperidine derivative 8 was obtained treating compound 4{1,1,6} with 20% TFA in 
dichloromethane. The presence of unprotected primary amide, carboxylic acid and secondary amine groups 
in compounds 6, 7 and 8 respectively, can be of interest for modulation of drug-like properties. Moreover, it 
makes such transformed compounds also suitable for further elaborations, included application in 
peptidomimetic chemistry. 
 
Scheme 4. Further post-transformation reactions on selected UJ-3 CR products. 
 In order to evaluate if our compounds were suitable in drug discovery programs, we calculated their 
physicochemical properties using DruLiTo13 (all calculation details are provided in the SI file). Almost all 
compounds were drug-like according to the Rule of Five (Ro5) proposed by Lipinski,14 with only a few of them 
exceeding the limit of 500 MW. All compounds have calculated octanol/water partition (LogP) lower than 5, 
with the highly hydrophilic area (LogP < 3) mostly populated (Figure 5). 
 
Figure 5. Drug- and lead-likeness (MW/LogP) of all the products obtained in this work. Blue-spots: Ugi-Joullié 
products 4, orange-spots: azido-Ugi products 5, grey-spots: post-transformation products 6,7 and 8. 
 
Concerning the other Ro5 properties, all the synthesised compounds have hydrogen bonding donator groups 
(HBD) lower than five and hydrogen bonding acceptor groups (HBA) lower than 10 (Figure 6). These data, 
and in addition the presence of rotational bonds (RB) lower than 10 and the polar surface area prediction 
(TPSA) lower than 140 Å2 (see SI), according to Veber’s rule,15 make definitively our compounds of potential 
interest from the pharmacological point of view. 
 
 
Figure 6. Calculated hydrogen bonding donators (HBD, blue-bars), hydrogen bonding acceptors (HBA, red-
bars) and rotational bonds (RB, green-bars) for all the synthesised compounds.  
 
 
Conclusions 
In conclusion, we have efficiently synthesized two structurally diverse libraries of highly functionalized 
spiooxindole thiazolidines, via Ugi-Joullié and azido-Ugi multicomponent reactions. The MCR-derived central 
spiro scaffold was effectively functionalized with a variety of lipophilic and polar appendages, as well as with 
tetrazole as a carboxylic acid isostere. The products were obtained in generally high yields, with simple 
workup procedures and straightforward isolation. The observed high diastereoselectivity for both the 
transformations is particularly noteworthy. Given the interesting physicochemical properties of these 
products, biological evaluation16 of compounds 4 and 5 is currently ongoing in collaboration with Merck 
Pharma®.  
 Experimental Section 
General remarks and chemicals All commercial materials (Aldrich, Fluka, Fluorochem) were used without 
further purification. All solvents were of reagent grade or HPLC grade. Reactions requiring anhydrous 
conditions were performed under nitrogen atmosphere. All reactions were monitored by thin layer 
chromatography (TLC) on precoated silica gel 60 F254; spots were visualized with UV light (254 nm) or by 
treatment with KMnO4 solution in water or ninhydrin solution in ethanol. Products were purified by flash 
chromatography on silica gel 60 (230–400 mesh). 1H NMR spectra and 13C NMR, COSY, HSQC and HMBC 
spectra were recorded on 300, 400 and 500 MHz spectrometers. 13C NMR spectra have been recorded using 
the APT pulse sequence. The number of carbons reported in the 13C data are derived from the HMBC 
(Heteronuclear Multiple Bond Correlation) experiment. Chemical shifts are reported in parts per million 
relative to the residual solvent. Multiplicities in 1H NMR are reported as follows: s = singlet, d = doublet, t = 
triplet, m = multiplet, br s = broad singlet. High-resolution MS spectra (HR-MS) were recorded with a Waters 
Micromass Q-ToF micro TM mass spectrometer, equipped with an ESI source. 
Unless otherwise noted, materials obtained from commercial suppliers were used without further 
purification. Thiazolines 1 were synthesized according to our previous work.4  
Representative procedure for Ugi-Joullié 3-CR reaction. To a solution of thiazoline 1{1} (0.3 mmol, 1 eq) 
in TFE (0.62 mL), isocyanide 2{1} (0.3 mmol, 1 eq) and the carboxylic acid 3{1} (0.3 mmol, 1.0 eq) were 
added at room temperature. The reaction was stirred and the conversion was monitored by TLC. The 
solvent was removed under reduced pressure and the crude was purified by flash chromatography 
(FC) obtaining the pure trans-diastereoisomer (Rf major, with respect to the cis-diastereoisomer), 
which was fully characterised as reported below. 
(3S*,4'R*)-N-(tert-butyl)-3'-(cyclohexanecarbonyl)-1-methyl-2-oxospiro[indoline-3,2'-thiazolidine]-4'- 
carboxamide (4{1,1,1}). FC: CH2Cl2:EtOAc, 95:5; yield: 83%; grey foamy solid; 1H NMR (300 MHz, CDCl3, 
4:1 mixture of two rotamers) δ 7.43-7.18 (m, 2H), 7.11 (t, br, J = 7.8Hz, 0.2H), 7.14 (t, br, J = 7.8Hz, 
0.8H), 6.95-6.86 (m, br, 0.4H), 6.83 (d, br, J = 7.8Hz, 0.8H),  6.52 (m, br, 0.8H), 5.42 (d, br,  J = 4.9 Hz, 
0.2H), 4.89 (d, J = 7.8 Hz, 0.8H), 4.04 (dd, J = 11.6 and 6.9 Hz, 0.8H), 3.69-3.57 (m, 0.4H), 3.45 (d, J = 
11.6 Hz, 0.8H), 3.26 (s, 0.6H), 3.22 (s, 2.4H), 2.25 (t, br, J = 10.7Hz, 0.8H), 1.84-1.08 (m, 10H methylene 
protons + 0.2H), 1.47 (s, 7.2H), 1.40 (s, 1.8H); 13C NMR (101 MHz, CDCl3) δ 177.3, 175.6 and 175.0 
(1C), 169.2 and 168.8 (1C), 143.7 and 142.2 (1C), 130.8 and 130.1 (1C), 127.3 and 126.1 (1C), 124.3 
and 123.8 (1C) 122.8 and 122.3 (1C), 109.1 and 108.9 (1C), 71.8, 66.8 and 66.2 (1C), 52.1 and 52.3 
(1C), 44.1 and 42.7 (1C), 33.4, 29.9 and 29.6 (2C), 28.7 (3C), 26.6, 25.4 and 25.3 (3C); HR-MS (ESI) 
calcd for C23H31N3NaO3S+ ([M+Na]+) 452.1978, found 452.1987. 
Representative procedure for azido-Ugi 3-CR reaction. To a solution of thiazoline 1{1} (0.3 mmol, 1 eq) 
in HFIP (0.68 mL) cooled to 0 °C, isocyanide 2{1} (0.3 mmol, 1 eq) and trimethylsilyl azide (0.3 mmol, 
1 eq) were added. The reaction was stirred at the same temperature and the conversion was 
monitored by TLC. The solvent was evaporated under reduce pressure and the crude was purified by 
flash chromatography (FC) obtaining the pure trans-diasteroisomer (Rf major, with respect to the cis-
diastereoisomer), which was fully characterised as reported below. 
(3S*,4'R*)-4'-(1-(tert-butyl)-1H-tetrazol-5-yl)-1-methylspiro[indoline-3,2'-thiazolidin]-2-one (5{1,1}). FC: 
CH2Cl2:EtOAc, from 100:0, to 96:4; yield: 87%; amorphous  solid; 1H NMR (300 MHz, CDCl3) δ 7.49 
(dd, J = 7.6, 1.3 Hz, 1H), 7.38 (td, J = 7.6, 1.3 Hz, 1H), 7.15 (td, J = 7.6, 1.3 Hz, 1H), 6.88 (d, J = 7.6, 1H), 
5.80 (dd, J = 9.5, 6.3 Hz, 1H), 4.00 - 3.90 (m, 1H), 3.75 (dd, J = 9.5, 6.3 Hz, 1H), 3.22 (s, 3H), 2.85 (br s, 
1H), 1.81 (s, 9H); 13C NMR (76 MHz, CDCl3) δ 176.4, 152.6, 143.3, 130.7, 126.4, 124.1, 123.6, 108.7, 
75.5, 62.1, 57.3, 41.0, 30.0 (3C), 29.8; HR-MS (ESI) calcd for  C16H21N6OS+ [MH]+ 345.1492, found 
345.1512. 
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